Virax Biolabs Group Ltd - Ordinary Shares - Class A

NASDAQ:VRAX  
1.01
-0.19 (-15.83%)
7:59:35 PM EDT: $1.06 +0.05 (+4.95%)
Equity Financing / Related

Virax Biolabs Files Prospectus Related To Resale Of 5.8 Mln Ordinary Shares

Published: 11/21/2022 11:58 GMT
Virax Biolabs Group Ltd - Ordinary Shares - Class A (VRAX) - Virax Biolabs Group Ltd Files Prospectus Relates to Resale by Selling Shareholders From Time to Time of Up to 5.8 Million of Ordinary Shares.
Further Company Coverage: Vraxo ((reuters.
Briefs@thomsonreuters.
Com;)).